2015-2027 Global Neurological Biomarkers Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
The worldwide market for Neurological Biomarkers is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Aepodia
Thermo Fisher Scientific
AbaStar MDx
QIAGEN
Myriad RBM
Cisbio Bioassays
Proteome Sciences
Athena Diagnostics
Acumen Pharmaceuticals
ImmunArray
Quanterix
Abiant
Major Types Covered
Alzheimer's disease (AD)
Multiple sclerosis (MS)
Parkinson's disease (PD)
Autism spectrum disorder (ASD)
Major Applications Covered
Hospitals
Clinics
Diagnostic and research laboratories
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Aepodia
Thermo Fisher Scientific
AbaStar MDx
QIAGEN
Myriad RBM
Cisbio Bioassays
Proteome Sciences
Athena Diagnostics
Acumen Pharmaceuticals
ImmunArray
Quanterix
Abiant
Major Types Covered
Alzheimer's disease (AD)
Multiple sclerosis (MS)
Parkinson's disease (PD)
Autism spectrum disorder (ASD)
Major Applications Covered
Hospitals
Clinics
Diagnostic and research laboratories
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Neurological Biomarkers Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Neurological Biomarkers Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE NEUROLOGICAL BIOMARKERS MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL NEUROLOGICAL BIOMARKERS MARKET-SEGMENTATION BY TYPE
5.1 Alzheimer's disease (AD)
5.2 Multiple sclerosis (MS)
5.3 Parkinson's disease (PD)
5.4 Autism spectrum disorder (ASD)
6 GLOBAL NEUROLOGICAL BIOMARKERS MARKET-SEGMENTATION BY APPLICATION
6.1 Hospitals
6.2 Clinics
6.3 Diagnostic and research laboratories
7 GLOBAL NEUROLOGICAL BIOMARKERS MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Aepodia
8.1.1 Aepodia Profile
8.1.2 Aepodia Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Aepodia Product/Solution Launches and Enhancements Analysis
8.1.4 Aepodia Business Overview/Recent Development/Acquisitions
8.2 Thermo Fisher Scientific
8.2.1 Thermo Fisher Scientific Profile
8.2.2 Thermo Fisher Scientific Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Thermo Fisher Scientific Product/Solution Launches and Enhancements Analysis
8.2.4 Thermo Fisher Scientific Business Overview/Recent Development/Acquisitions
8.3 AbaStar MDx
8.3.1 AbaStar MDx Profile
8.3.2 AbaStar MDx Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 AbaStar MDx Product/Solution Launches and Enhancements Analysis
8.3.4 AbaStar MDx Business Overview/Recent Development/Acquisitions
8.4 QIAGEN
8.4.1 QIAGEN Profile
8.4.2 QIAGEN Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 QIAGEN Product/Solution Launches and Enhancements Analysis
8.4.4 QIAGEN Business Overview/Recent Development/Acquisitions
8.5 Myriad RBM
8.5.1 Myriad RBM Profile
8.5.2 Myriad RBM Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Myriad RBM Product/Solution Launches and Enhancements Analysis
8.5.4 Myriad RBM Business Overview/Recent Development/Acquisitions
8.6 Cisbio Bioassays
8.6.1 Cisbio Bioassays Profile
8.6.2 Cisbio Bioassays Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Cisbio Bioassays Product/Solution Launches and Enhancements Analysis
8.6.4 Cisbio Bioassays Business Overview/Recent Development/Acquisitions
8.7 Proteome Sciences
8.7.1 Proteome Sciences Profile
8.7.2 Proteome Sciences Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Proteome Sciences Product/Solution Launches and Enhancements Analysis
8.7.4 Proteome Sciences Business Overview/Recent Development/Acquisitions
8.8 Athena Diagnostics
8.8.1 Athena Diagnostics Profile
8.8.2 Athena Diagnostics Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Athena Diagnostics Product/Solution Launches and Enhancements Analysis
8.8.4 Athena Diagnostics Business Overview/Recent Development/Acquisitions
8.9 Acumen Pharmaceuticals
8.9.1 Acumen Pharmaceuticals Profile
8.9.2 Acumen Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Acumen Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.9.4 Acumen Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.10 ImmunArray
8.10.1 ImmunArray Profile
8.10.2 ImmunArray Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 ImmunArray Product/Solution Launches and Enhancements Analysis
8.10.4 ImmunArray Business Overview/Recent Development/Acquisitions
8.11 Quanterix
8.11.1 Quanterix Profile
8.11.2 Quanterix Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Quanterix Product/Solution Launches and Enhancements Analysis
8.11.4 Quanterix Business Overview/Recent Development/Acquisitions
8.12 Abiant
8.12.1 Abiant Profile
8.12.2 Abiant Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Abiant Product/Solution Launches and Enhancements Analysis
8.12.4 Abiant Business Overview/Recent Development/Acquisitions
9 GLOBAL NEUROLOGICAL BIOMARKERS MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Neurological Biomarkers Production Analysis from 2015-2020
10.4 North America Neurological Biomarkers Consumption Analysis from 2015-2020
10.5 North America Neurological Biomarkers Import and Export from 2015-2020
10.6 North America Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
10.7 North America Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Neurological Biomarkers by Country (United States, Canada)
10.8.1 North America Neurological Biomarkers Sales by Country (2015-2020)
10.8.2 North America Neurological Biomarkers Consumption Value by Country (2015-2020)
10.9 North America Neurological Biomarkers Market PEST Analysis
11 EUROPE
11.1 Europe Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Neurological Biomarkers Production Analysis from 2015-2020
11.4 Europe Neurological Biomarkers Consumption Analysis from 2015-2020
11.5 Europe Neurological Biomarkers Import and Export from 2015-2020
11.6 Europe Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
11.7 Europe Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Neurological Biomarkers by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Neurological Biomarkers Sales by Country (2015-2020)
11.8.2 Europe Neurological Biomarkers Consumption Value by Country (2015-2020)
11.9 Europe Neurological Biomarkers Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Neurological Biomarkers Production Analysis from 2015-2020
12.4 Asia-Pacific Neurological Biomarkers Consumption Analysis from 2015-2020
12.5 Asia-Pacific Neurological Biomarkers Import and Export from 2015-2020
12.6 Asia-Pacific Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Neurological Biomarkers by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Neurological Biomarkers Sales by Country (2015-2020)
12.8.2 Asia-Pacific Neurological Biomarkers Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Neurological Biomarkers Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Neurological Biomarkers Production Analysis from 2015-2020
13.4 Latin America Neurological Biomarkers Consumption Analysis from 2015-2020
13.5 Latin America Neurological Biomarkers Import and Export from 2015-2020
13.6 Latin America Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Neurological Biomarkers by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Neurological Biomarkers Sales by Country (2015-2020)
13.8.2 Latin America Neurological Biomarkers Consumption Value by Country (2015-2020)
13.9 Latin America Neurological Biomarkers Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Neurological Biomarkers Production Analysis from 2015-2020
14.4 Middle East & Africa Neurological Biomarkers Consumption Analysis from 2015-2020
14.5 Middle East & Africa Neurological Biomarkers Import and Export from 2015-2020
14.6 Middle East & Africa Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Neurological Biomarkers by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Neurological Biomarkers Sales by Country (2015-2020)
14.8.2 Middle East & Africa Neurological Biomarkers Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Neurological Biomarkers Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL NEUROLOGICAL BIOMARKERS MARKET FROM 2020-2027
15.1 Future Forecast of the Global Neurological Biomarkers Market from 2020-2027 Segment by Region
15.2 Global Neurological Biomarkers Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Neurological Biomarkers Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Neurological Biomarkers Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Neurological Biomarkers Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE NEUROLOGICAL BIOMARKERS MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL NEUROLOGICAL BIOMARKERS MARKET-SEGMENTATION BY TYPE
5.1 Alzheimer's disease (AD)
5.2 Multiple sclerosis (MS)
5.3 Parkinson's disease (PD)
5.4 Autism spectrum disorder (ASD)
6 GLOBAL NEUROLOGICAL BIOMARKERS MARKET-SEGMENTATION BY APPLICATION
6.1 Hospitals
6.2 Clinics
6.3 Diagnostic and research laboratories
7 GLOBAL NEUROLOGICAL BIOMARKERS MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Aepodia
8.1.1 Aepodia Profile
8.1.2 Aepodia Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Aepodia Product/Solution Launches and Enhancements Analysis
8.1.4 Aepodia Business Overview/Recent Development/Acquisitions
8.2 Thermo Fisher Scientific
8.2.1 Thermo Fisher Scientific Profile
8.2.2 Thermo Fisher Scientific Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Thermo Fisher Scientific Product/Solution Launches and Enhancements Analysis
8.2.4 Thermo Fisher Scientific Business Overview/Recent Development/Acquisitions
8.3 AbaStar MDx
8.3.1 AbaStar MDx Profile
8.3.2 AbaStar MDx Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 AbaStar MDx Product/Solution Launches and Enhancements Analysis
8.3.4 AbaStar MDx Business Overview/Recent Development/Acquisitions
8.4 QIAGEN
8.4.1 QIAGEN Profile
8.4.2 QIAGEN Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 QIAGEN Product/Solution Launches and Enhancements Analysis
8.4.4 QIAGEN Business Overview/Recent Development/Acquisitions
8.5 Myriad RBM
8.5.1 Myriad RBM Profile
8.5.2 Myriad RBM Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Myriad RBM Product/Solution Launches and Enhancements Analysis
8.5.4 Myriad RBM Business Overview/Recent Development/Acquisitions
8.6 Cisbio Bioassays
8.6.1 Cisbio Bioassays Profile
8.6.2 Cisbio Bioassays Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Cisbio Bioassays Product/Solution Launches and Enhancements Analysis
8.6.4 Cisbio Bioassays Business Overview/Recent Development/Acquisitions
8.7 Proteome Sciences
8.7.1 Proteome Sciences Profile
8.7.2 Proteome Sciences Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Proteome Sciences Product/Solution Launches and Enhancements Analysis
8.7.4 Proteome Sciences Business Overview/Recent Development/Acquisitions
8.8 Athena Diagnostics
8.8.1 Athena Diagnostics Profile
8.8.2 Athena Diagnostics Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Athena Diagnostics Product/Solution Launches and Enhancements Analysis
8.8.4 Athena Diagnostics Business Overview/Recent Development/Acquisitions
8.9 Acumen Pharmaceuticals
8.9.1 Acumen Pharmaceuticals Profile
8.9.2 Acumen Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Acumen Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.9.4 Acumen Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.10 ImmunArray
8.10.1 ImmunArray Profile
8.10.2 ImmunArray Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 ImmunArray Product/Solution Launches and Enhancements Analysis
8.10.4 ImmunArray Business Overview/Recent Development/Acquisitions
8.11 Quanterix
8.11.1 Quanterix Profile
8.11.2 Quanterix Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Quanterix Product/Solution Launches and Enhancements Analysis
8.11.4 Quanterix Business Overview/Recent Development/Acquisitions
8.12 Abiant
8.12.1 Abiant Profile
8.12.2 Abiant Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Abiant Product/Solution Launches and Enhancements Analysis
8.12.4 Abiant Business Overview/Recent Development/Acquisitions
9 GLOBAL NEUROLOGICAL BIOMARKERS MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Neurological Biomarkers Production Analysis from 2015-2020
10.4 North America Neurological Biomarkers Consumption Analysis from 2015-2020
10.5 North America Neurological Biomarkers Import and Export from 2015-2020
10.6 North America Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
10.7 North America Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Neurological Biomarkers by Country (United States, Canada)
10.8.1 North America Neurological Biomarkers Sales by Country (2015-2020)
10.8.2 North America Neurological Biomarkers Consumption Value by Country (2015-2020)
10.9 North America Neurological Biomarkers Market PEST Analysis
11 EUROPE
11.1 Europe Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Neurological Biomarkers Production Analysis from 2015-2020
11.4 Europe Neurological Biomarkers Consumption Analysis from 2015-2020
11.5 Europe Neurological Biomarkers Import and Export from 2015-2020
11.6 Europe Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
11.7 Europe Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Neurological Biomarkers by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Neurological Biomarkers Sales by Country (2015-2020)
11.8.2 Europe Neurological Biomarkers Consumption Value by Country (2015-2020)
11.9 Europe Neurological Biomarkers Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Neurological Biomarkers Production Analysis from 2015-2020
12.4 Asia-Pacific Neurological Biomarkers Consumption Analysis from 2015-2020
12.5 Asia-Pacific Neurological Biomarkers Import and Export from 2015-2020
12.6 Asia-Pacific Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Neurological Biomarkers by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Neurological Biomarkers Sales by Country (2015-2020)
12.8.2 Asia-Pacific Neurological Biomarkers Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Neurological Biomarkers Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Neurological Biomarkers Production Analysis from 2015-2020
13.4 Latin America Neurological Biomarkers Consumption Analysis from 2015-2020
13.5 Latin America Neurological Biomarkers Import and Export from 2015-2020
13.6 Latin America Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Neurological Biomarkers by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Neurological Biomarkers Sales by Country (2015-2020)
13.8.2 Latin America Neurological Biomarkers Consumption Value by Country (2015-2020)
13.9 Latin America Neurological Biomarkers Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Neurological Biomarkers Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Neurological Biomarkers Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Neurological Biomarkers Production Analysis from 2015-2020
14.4 Middle East & Africa Neurological Biomarkers Consumption Analysis from 2015-2020
14.5 Middle East & Africa Neurological Biomarkers Import and Export from 2015-2020
14.6 Middle East & Africa Neurological Biomarkers Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Neurological Biomarkers Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Neurological Biomarkers by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Neurological Biomarkers Sales by Country (2015-2020)
14.8.2 Middle East & Africa Neurological Biomarkers Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Neurological Biomarkers Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL NEUROLOGICAL BIOMARKERS MARKET FROM 2020-2027
15.1 Future Forecast of the Global Neurological Biomarkers Market from 2020-2027 Segment by Region
15.2 Global Neurological Biomarkers Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Neurological Biomarkers Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
LIST OF TABLES AND FIGURES
Global Neurological Biomarkers Market Value ($) and Growth Rate of Neurological Biomarkers from 2015-2027
Global Neurological Biomarkers Production and Growth Rate Segment by Product Type from 2015-2027
Global Neurological Biomarkers Consumption and Growth Rate Segment by Application from 2015-2027
Figure Neurological Biomarkers Picture
Table Product Specifications of Neurological Biomarkers
Table Driving Factors for this Market
Table Industry News of Neurological Biomarkers Market
Figure Value Chain Status of Neurological Biomarkers
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Neurological Biomarkers Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Neurological Biomarkers Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Alzheimer's disease (AD) of Neurological Biomarkers
Figure Multiple sclerosis (MS) of Neurological Biomarkers
Figure Parkinson's disease (PD) of Neurological Biomarkers
Figure Autism spectrum disorder (ASD) of Neurological Biomarkers
Table Global Neurological Biomarkers Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Neurological Biomarkers Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospitals of Neurological Biomarkers
Figure Clinics of Neurological Biomarkers
Figure Diagnostic and research laboratories of Neurological Biomarkers
Table Global Neurological Biomarkers Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Neurological Biomarkers Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Neurological Biomarkers
Figure Online Channel of Neurological Biomarkers
Table Aepodia Profile (Company Name, Plants Distribution, Sales Region)
Figure Aepodia Sales and Growth Rate from 2015-2020
Figure Aepodia Revenue ($) and Global Market Share from 2015-2020
Table Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Thermo Fisher Scientific Profile (Company Name, Plants Distribution, Sales Region)
Figure Thermo Fisher Scientific Sales and Growth Rate from 2015-2020
Figure Thermo Fisher Scientific Revenue ($) and Global Market Share from 2015-2020
Table Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table AbaStar MDx Profile (Company Name, Plants Distribution, Sales Region)
Figure AbaStar MDx Sales and Growth Rate from 2015-2020
Figure AbaStar MDx Revenue ($) and Global Market Share from 2015-2020
Table AbaStar MDx Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table QIAGEN Profile (Company Name, Plants Distribution, Sales Region)
Figure QIAGEN Sales and Growth Rate from 2015-2020
Figure QIAGEN Revenue ($) and Global Market Share from 2015-2020
Table QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Myriad RBM Profile (Company Name, Plants Distribution, Sales Region)
Figure Myriad RBM Sales and Growth Rate from 2015-2020
Figure Myriad RBM Revenue ($) and Global Market Share from 2015-2020
Table Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Cisbio Bioassays Profile (Company Name, Plants Distribution, Sales Region)
Figure Cisbio Bioassays Sales and Growth Rate from 2015-2020
Figure Cisbio Bioassays Revenue ($) and Global Market Share from 2015-2020
Table Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Proteome Sciences Profile (Company Name, Plants Distribution, Sales Region)
Figure Proteome Sciences Sales and Growth Rate from 2015-2020
Figure Proteome Sciences Revenue ($) and Global Market Share from 2015-2020
Table Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Athena Diagnostics Profile (Company Name, Plants Distribution, Sales Region)
Figure Athena Diagnostics Sales and Growth Rate from 2015-2020
Figure Athena Diagnostics Revenue ($) and Global Market Share from 2015-2020
Table Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Acumen Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Acumen Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Acumen Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Acumen Pharmaceuticals Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table ImmunArray Profile (Company Name, Plants Distribution, Sales Region)
Figure ImmunArray Sales and Growth Rate from 2015-2020
Figure ImmunArray Revenue ($) and Global Market Share from 2015-2020
Table ImmunArray Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Quanterix Profile (Company Name, Plants Distribution, Sales Region)
Figure Quanterix Sales and Growth Rate from 2015-2020
Figure Quanterix Revenue ($) and Global Market Share from 2015-2020
Table Quanterix Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abiant Profile (Company Name, Plants Distribution, Sales Region)
Figure Abiant Sales and Growth Rate from 2015-2020
Figure Abiant Revenue ($) and Global Market Share from 2015-2020
Table Abiant Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Neurological Biomarkers Production Value ($) by Region from 2015-2020
Table Global Neurological Biomarkers Production Value Share by Region from 2015-2020
Table Global Neurological Biomarkers Production by Region from 2015-2020
Table Global Neurological Biomarkers Consumption Value ($) by Region from 2015-2020
Table Global Neurological Biomarkers Consumption by Region from 2015-2020
Table North America Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Neurological Biomarkers Import and Export from 2015-2020
Table North America Neurological Biomarkers Value ($) by Type (2015-2020)
Table North America Neurological Biomarkers Production by Type (2015-2020)
Table North America Neurological Biomarkers Consumption by Application (2015-2020)
Table North America Neurological Biomarkers Consumption by Country (2015-2020)
Table North America Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure North America Neurological Biomarkers Market PEST Analysis
Table Europe Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Neurological Biomarkers Import and Export from 2015-2020
Table Europe Neurological Biomarkers Value ($) by Type (2015-2020)
Table Europe Neurological Biomarkers Production by Type (2015-2020)
Table Europe Neurological Biomarkers Consumption by Application (2015-2020)
Table Europe Neurological Biomarkers Consumption by Country (2015-2020)
Table Europe Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure Europe Neurological Biomarkers Market PEST Analysis
Table Asia-Pacific Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Neurological Biomarkers Import and Export from 2015-2020
Table Asia-Pacific Neurological Biomarkers Value ($) by Type (2015-2020)
Table Asia-Pacific Neurological Biomarkers Production by Type (2015-2020)
Table Asia-Pacific Neurological Biomarkers Consumption by Application (2015-2020)
Table Asia-Pacific Neurological Biomarkers Consumption by Country (2015-2020)
Table Asia-Pacific Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Neurological Biomarkers Market PEST Analysis
Table Latin America Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Neurological Biomarkers Import and Export from 2015-2020
Table Latin America Neurological Biomarkers Value ($) by Type (2015-2020)
Table Latin America Neurological Biomarkers Production by Type (2015-2020)
Table Latin America Neurological Biomarkers Consumption by Application (2015-2020)
Table Latin America Neurological Biomarkers Consumption by Country (2015-2020)
Table Latin America Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure Latin America Neurological Biomarkers Market PEST Analysis
Table Middle East & Africa Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Neurological Biomarkers Import and Export from 2015-2020
Table Middle East & Africa Neurological Biomarkers Value ($) by Type (2015-2020)
Table Middle East & Africa Neurological Biomarkers Production by Type (2015-2020)
Table Middle East & Africa Neurological Biomarkers Consumption by Application (2015-2020)
Table Middle East & Africa Neurological Biomarkers Consumption by Country (2015-2020)
Table Middle East & Africa Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Neurological Biomarkers Market PEST Analysis
Table Global Neurological Biomarkers Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Neurological Biomarkers Production and Growth Rate Forecast by Region (2020-2027)
Table Global Neurological Biomarkers Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Neurological Biomarkers Production and Growth Rate Forecast by Type (2020-2027)
Table Global Neurological Biomarkers Consumption and Growth Rate Forecast by Application (2020-2027)
Global Neurological Biomarkers Market Value ($) and Growth Rate of Neurological Biomarkers from 2015-2027
Global Neurological Biomarkers Production and Growth Rate Segment by Product Type from 2015-2027
Global Neurological Biomarkers Consumption and Growth Rate Segment by Application from 2015-2027
Figure Neurological Biomarkers Picture
Table Product Specifications of Neurological Biomarkers
Table Driving Factors for this Market
Table Industry News of Neurological Biomarkers Market
Figure Value Chain Status of Neurological Biomarkers
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Neurological Biomarkers Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Neurological Biomarkers Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Alzheimer's disease (AD) of Neurological Biomarkers
Figure Multiple sclerosis (MS) of Neurological Biomarkers
Figure Parkinson's disease (PD) of Neurological Biomarkers
Figure Autism spectrum disorder (ASD) of Neurological Biomarkers
Table Global Neurological Biomarkers Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Neurological Biomarkers Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospitals of Neurological Biomarkers
Figure Clinics of Neurological Biomarkers
Figure Diagnostic and research laboratories of Neurological Biomarkers
Table Global Neurological Biomarkers Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Neurological Biomarkers Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Neurological Biomarkers
Figure Online Channel of Neurological Biomarkers
Table Aepodia Profile (Company Name, Plants Distribution, Sales Region)
Figure Aepodia Sales and Growth Rate from 2015-2020
Figure Aepodia Revenue ($) and Global Market Share from 2015-2020
Table Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Thermo Fisher Scientific Profile (Company Name, Plants Distribution, Sales Region)
Figure Thermo Fisher Scientific Sales and Growth Rate from 2015-2020
Figure Thermo Fisher Scientific Revenue ($) and Global Market Share from 2015-2020
Table Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table AbaStar MDx Profile (Company Name, Plants Distribution, Sales Region)
Figure AbaStar MDx Sales and Growth Rate from 2015-2020
Figure AbaStar MDx Revenue ($) and Global Market Share from 2015-2020
Table AbaStar MDx Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table QIAGEN Profile (Company Name, Plants Distribution, Sales Region)
Figure QIAGEN Sales and Growth Rate from 2015-2020
Figure QIAGEN Revenue ($) and Global Market Share from 2015-2020
Table QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Myriad RBM Profile (Company Name, Plants Distribution, Sales Region)
Figure Myriad RBM Sales and Growth Rate from 2015-2020
Figure Myriad RBM Revenue ($) and Global Market Share from 2015-2020
Table Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Cisbio Bioassays Profile (Company Name, Plants Distribution, Sales Region)
Figure Cisbio Bioassays Sales and Growth Rate from 2015-2020
Figure Cisbio Bioassays Revenue ($) and Global Market Share from 2015-2020
Table Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Proteome Sciences Profile (Company Name, Plants Distribution, Sales Region)
Figure Proteome Sciences Sales and Growth Rate from 2015-2020
Figure Proteome Sciences Revenue ($) and Global Market Share from 2015-2020
Table Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Athena Diagnostics Profile (Company Name, Plants Distribution, Sales Region)
Figure Athena Diagnostics Sales and Growth Rate from 2015-2020
Figure Athena Diagnostics Revenue ($) and Global Market Share from 2015-2020
Table Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Acumen Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Acumen Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Acumen Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Acumen Pharmaceuticals Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table ImmunArray Profile (Company Name, Plants Distribution, Sales Region)
Figure ImmunArray Sales and Growth Rate from 2015-2020
Figure ImmunArray Revenue ($) and Global Market Share from 2015-2020
Table ImmunArray Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Quanterix Profile (Company Name, Plants Distribution, Sales Region)
Figure Quanterix Sales and Growth Rate from 2015-2020
Figure Quanterix Revenue ($) and Global Market Share from 2015-2020
Table Quanterix Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abiant Profile (Company Name, Plants Distribution, Sales Region)
Figure Abiant Sales and Growth Rate from 2015-2020
Figure Abiant Revenue ($) and Global Market Share from 2015-2020
Table Abiant Neurological Biomarkers Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Neurological Biomarkers Production Value ($) by Region from 2015-2020
Table Global Neurological Biomarkers Production Value Share by Region from 2015-2020
Table Global Neurological Biomarkers Production by Region from 2015-2020
Table Global Neurological Biomarkers Consumption Value ($) by Region from 2015-2020
Table Global Neurological Biomarkers Consumption by Region from 2015-2020
Table North America Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Neurological Biomarkers Import and Export from 2015-2020
Table North America Neurological Biomarkers Value ($) by Type (2015-2020)
Table North America Neurological Biomarkers Production by Type (2015-2020)
Table North America Neurological Biomarkers Consumption by Application (2015-2020)
Table North America Neurological Biomarkers Consumption by Country (2015-2020)
Table North America Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure North America Neurological Biomarkers Market PEST Analysis
Table Europe Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Neurological Biomarkers Import and Export from 2015-2020
Table Europe Neurological Biomarkers Value ($) by Type (2015-2020)
Table Europe Neurological Biomarkers Production by Type (2015-2020)
Table Europe Neurological Biomarkers Consumption by Application (2015-2020)
Table Europe Neurological Biomarkers Consumption by Country (2015-2020)
Table Europe Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure Europe Neurological Biomarkers Market PEST Analysis
Table Asia-Pacific Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Neurological Biomarkers Import and Export from 2015-2020
Table Asia-Pacific Neurological Biomarkers Value ($) by Type (2015-2020)
Table Asia-Pacific Neurological Biomarkers Production by Type (2015-2020)
Table Asia-Pacific Neurological Biomarkers Consumption by Application (2015-2020)
Table Asia-Pacific Neurological Biomarkers Consumption by Country (2015-2020)
Table Asia-Pacific Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Neurological Biomarkers Market PEST Analysis
Table Latin America Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Neurological Biomarkers Import and Export from 2015-2020
Table Latin America Neurological Biomarkers Value ($) by Type (2015-2020)
Table Latin America Neurological Biomarkers Production by Type (2015-2020)
Table Latin America Neurological Biomarkers Consumption by Application (2015-2020)
Table Latin America Neurological Biomarkers Consumption by Country (2015-2020)
Table Latin America Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure Latin America Neurological Biomarkers Market PEST Analysis
Table Middle East & Africa Neurological Biomarkers Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Neurological Biomarkers Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Neurological Biomarkers Import and Export from 2015-2020
Table Middle East & Africa Neurological Biomarkers Value ($) by Type (2015-2020)
Table Middle East & Africa Neurological Biomarkers Production by Type (2015-2020)
Table Middle East & Africa Neurological Biomarkers Consumption by Application (2015-2020)
Table Middle East & Africa Neurological Biomarkers Consumption by Country (2015-2020)
Table Middle East & Africa Neurological Biomarkers Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Neurological Biomarkers Market PEST Analysis
Table Global Neurological Biomarkers Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Neurological Biomarkers Production and Growth Rate Forecast by Region (2020-2027)
Table Global Neurological Biomarkers Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Neurological Biomarkers Production and Growth Rate Forecast by Type (2020-2027)
Table Global Neurological Biomarkers Consumption and Growth Rate Forecast by Application (2020-2027)
